John Blankenhorn

John Blankenhorn

InvestorPlace Contributor

Expertise: Biochemistry, biotechnology and pharmaceutical research

John Blankenhorn has been a researcher since 2016 and has years of experience and publications on the topics of biochemistry, biotechnology, and pharmaceutical research. His main interests are the application of biology and biotechnology to our daily lives, as well as the use of Machine Learning and AI to speed up research and development in the life sciences. He currently works at Emory University studying the structural basis of Alzheimer’s Disease.

Recent Articles

3 Millionaire-Maker Next-Gen Telecom Stocks to Buy and Hold Forever

By John Blankenhorn, InvestorPlace Contributor

The next millionaire-maker telecom stocks may not be ones you've heard about. Don't miss out on a generational opportunity.

3 Millionaire-Maker Machine Learning Stocks to Buy And Hold Forever

By John Blankenhorn, InvestorPlace Contributor

The AI revolution is already transforming both art and science. Here's three stocks which will also transform your portfolio.

3 Cloud Computing Stocks to Buy With Explosive Upside Potential

By John Blankenhorn, InvestorPlace Contributor

The best cloud computing stocks of tomorrow may not come from among the current dominant cloud companies. Here are three to look out for.

Top 3 Agricultural and Heavy-Duty Machinery Companies to Watch

By John Blankenhorn, InvestorPlace Contributor

Agricultural machinery stocks are key to making more with less. Good for sustainability, good for beating inflation, good for investors.

3 Gene Testing Stocks to Buy Before They Take Off

By John Blankenhorn, InvestorPlace Contributor

The future of gene testing is bright thanks to an aging population. Here are three companies leading the industry.

Load More